In glioma tissues, TRIM32 is up-regulated, and its knockdown inhibits cell growth by inducing apoptosis through both p53-dependent and p53-independent mechanisms, identifying TRIM32 as a potential anti-tumor target [33]. Here, TP53 is linked to neoplasm.